http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005053740-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6093 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
filingDate | 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2005053740-A1 |
titleOfInvention | Immune enhancer and enhanced antigen using the same |
abstract | An object of the present invention is to provide an immunopotentiator that enables immunization with efficiency exceeding conventional methods, and an enhanced antigen using the same. The immunopotentiator to which the present invention is applied mainly comprises a styrenic porous material and / or hydroxyapatite. The styrenic porous material is preferably a crosslinked styrenic porous polymer bead, and the hydroxyapatite material is preferably a porous bead. The enhanced antigen to which the present invention is applied comprises a carrier containing this immunopotentiator and an antigen adsorbed on the carrier. |
priorityDate | 2003-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.